Cardiology
Q&A
Losartan more effective than atenolol in hypertension with left ventricular hypertrophy
Dahlof B, Devereaux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in...
Applied Evidence
Outpatient treatment of heart failure
Original Research
General health screenings to improve cardiovascular risk profiles: A randomized controlled trial in general practice with 5-year follow-up
Q&A
β-Blockers decrease cardiac events in major noncardiac surgery
Auerbach AD, Goldman L. β-Blockers and reduction of cardiac events in noncardiac surgery. Scientific review. JAMA 2002; 287:1435–44.
Q&A
Angiotensin receptor blockers not equivalent to ACE inhibitors for heart failure
Jong P, Demers C, McKelvie RS, Liu PP. Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials. J Am Coll...
Q&A
No benefit to adding warfarin to aspirin after heart attack
Fiore LD, Ezekowitz MD, Brophy MT, Lu D, Sacco J, Peducci P. Department of veterans affairs cooperative studies program clinical trial comparing...
Clinical Inquiries
What levels of cholesterol should be treated for primary prevention?
EVIDENCE-BASED ANSWER: The levels of cholesterol that should be treated for primary prevention are based on low-density lipoprotein cholesterol (...
Q&A
Can aspirin prevent cardiovascular events in patients without known cardiovascular disease?
Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the US...
Q&A
Does raloxifene affect risk of cardiovascular events in osteoporotic postmenopausal women?
Barrett-Connor E, Grady D, Sashegyi A, et al. Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from...
Q&A
How do calcium channel blockers compare with beta-blockers, diuretics, and angiotensin-converting enzyme inhibitors for hypertension?
Opie LH, Schall R. Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative...
Q&A
What is the relative cardiovascular benefit of lowering cholesterol, blood pressure, and glucose levels in patients with type 2 diabetes?
Huang ES, Meigs JB, Singer DE. The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med...